JMPWA
IMNM icon

JP Morgan Private Wealth Advisors’s Immunome IMNM Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,270
Closed -$87K – 1966
2022
Q1 		$87K Buy
+15,270
New +$114K ﹤0.01% 1954

Other funds holding IMNM

PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Private Wealth Advisors's IMNM Position: Q2 2022 in Review

JP Morgan Private Wealth Advisors sold out of Immunome (IMNM) in Q2 2022, closing a stake of 15,270 shares — an estimated $87K sold.

JP Morgan Private Wealth Advisors first reported a position in IMNM in Q1 2022 and held it in 1 quarter. The position peaked at $87K in Q1 2022. 26 funds tracked by Wall St. Rank hold IMNM as of Q2 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Immunome position as of Q2 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 15,270 Immunome shares in Q2 2022, an estimated $87K.
  • JP Morgan Private Wealth Advisors first reported a position in Immunome in Q1 2022 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Immunome position peaked at $87K in Q1 2022.
  • 26 funds tracked by Wall St. Rank held Immunome as of Q2 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2022, filed 16 Aug 2022.